Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.67), in-line with the analyst estimate of ($0.67). Revenue for the quarter came in at $1.33 million versus the consensus estimate of $1.4 million.

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.